| Symbol | MTEX |
|---|---|
| Name | MANNATECH INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals & Botanical Products |
| Address | 1410 LAKESIDE PARKWAY, FLOWER MOUND, TX 75028 |
| Telephone | 9724717400 |
| Fax | — |
| — | |
| Website | https://www.mannatech.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001056358 |
| Description | Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from Asia/Pacific, followed by the Americas. Additional info from NASDAQ: |
Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
Read moreDirector TOTH ROBERT 🟢 acquired 5.0K shares (1 derivative) of MANNATECH INC (MTEX) at $5.77 Transaction Date: Jun 03, 2026 | Filing ID: 019673
Read moreDirector John Seifrick A 🟢 acquired 5.0K shares (1 derivative) of MANNATECH INC (MTEX) at $5.77 Transaction Date: Jun 03, 2026 | Filing ID: 019671
Read moreDirector JOBE LARRY A 🟢 acquired 2.8K shares of MANNATECH INC (MTEX) at $4.12 Transaction Date: May 20, 2026 | Filing ID: 018019
Read moreDirector JOBE LARRY A 🟢 acquired 5.0K shares of MANNATECH INC (MTEX) at $4.20 Transaction Date: May 19, 2026 | Filing ID: 017916
Read moreDirector Robbins Kevin Andrew 🟢 acquired 7.1K shares of MANNATECH INC (MTEX) at $4.17 Transaction Date: May 19, 2026 | Filing ID: 017908
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT05510050 | Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and R… | Na | Microbiome | Completed | 2022-05-13 | 2023-03-03 | ClinicalTrials.gov |
| NCT04386226 | An Assessment of the Glyconutrient Ambrotose™ on Immunity, Gut Health, and Safe… | Na | Healthy | Completed | 2018-08-15 | 2019-06-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Placebo | Other | Approved | Healthy | COMPLETED | NCT04386226 |
| Advanced Ambrotose | Other | Approved | Healthy | COMPLETED | NCT04386226 |
| Ambrotose LIFE | Other | Approved | Healthy | COMPLETED | NCT04386226 |
| Aloe Vera Extract 2 | Other | Approved | Microbiome | COMPLETED | NCT05510050 |
| Control | Other | Approved | Microbiome | COMPLETED | NCT05510050 |
| Aloe Vera Extract 1 | Other | Approved | Microbiome | COMPLETED | NCT05510050 |
| Placebo | Other | Approved | Healthy | COMPLETED | NCT04386226 |
| Advanced Ambrotose | Other | Approved | Healthy | COMPLETED | NCT04386226 |
| Ambrotose LIFE | Other | Approved | Healthy | COMPLETED | NCT04386226 |